- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07591675
Comparison of Combined Sprint-Plyometric Training Versus Traditional Strength Training on Speed, Agility, Power, and Movement Quality in Intermediate Rugby Players
15. maj 2026 opdateret af: Hafsah Gul Khattak, Ibadat International University, Islamabad
Comparison of Combined Sprint-Plyometric Training Versus Traditional Strength Training on Speed, Agility, Power, and Movement Quality in Intermediate Rugby Players: A Randomized Controlled Trial
Comparison of Combined Sprint-Plyometric Training Versus Traditional Strength Training on Speed, Agility, Power, and Movement Quality in Intermediate Rugby Players: A Randomized Controlled Trial
Studieoversigt
Status
Rekruttering
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This randomized controlled trial compares combined sprint-plyometric training (Group A) versus traditional strength training (Group B) in 64 intermediate-level rugby players (aged 18-25 years).
Both interventions are delivered over 8 weeks at 2 sessions per week.
Primary and secondary outcomes include speed (40 m and 80 m sprint via electronic timing gates), agility (T-Test), lower-body explosive power (Standing Long Jump), and movement quality (Functional Movement Screen), assessed at baseline and post-intervention.
Randomization is performed via computer-generated sequence.
Undersøgelsestype
Interventionel
Tilmelding (Anslået)
64
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Munazza Ahmed, MS Sports Physical Therapy
- Telefonnummer: +923295048527
- E-mail: munazzaahmed39@gmail.com
Studiesteder
-
-
-
Islamabad, Pakistan, 46000
- Rekruttering
- Ibadat International University, Islamabad (Iiui)
-
Kontakt:
- Hafsah Gul Khattak, DPT, MS-NMPT
- Telefonnummer: 923457170732
- E-mail: hafsahgull_khattak@yahoo.com
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
Tager imod sunde frivillige
Ja
Beskrivelse
Inclusion Criteria:
- Male and female athletes aged 18-25 years
- A minimum of 2 years of structured rugby training experience
- Actively training at least 3 hours per week
- Medically cleared to engage in high-intensity physical activity
- Willingness to participate and provide written informed consent
Exclusion Criteria:
- History of moderate or severe musculoskeletal injuries or surgery within the past 6-12 months
- Not medically approved to engage in high-intensity physical activities
- Cardiovascular or cardiopulmonary disease or risk factors that contraindicate high-intensity training
- Participation in any additional structured strength or plyometric program outside the study protocol during the intervention period
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Combined Sprint-Plyometric Training Group
Participants perform progressive sprint (10-100 m) and plyometric exercises (squat jumps, box jumps, single-leg hops, depth jumps) over 8 weeks.
Frequency: 2 sessions/week, 45-60 min/session.
Rest between sets: 3 minutes.
Rest between sessions: 48-72 hours.
Volume and distance progress across 4 two-week blocks.
|
Participants perform progressive sprint (10-100 m) and plyometric exercises (squat jumps, box jumps, single-leg hops, depth jumps) over 8 weeks.
Frequency: 2 sessions/week, 45-60 min/session.
Rest between sets: 3 minutes.
Rest between sessions: 48-72 hours.
Volume and distance progress across 4 two-week blocks
|
|
Aktiv komparator: Traditional Strength Training Group
Participants perform lower-body resistance exercises (barbell squat, leg press, lunges, Romanian deadlift, leg curl, leg extension) at 60-80% 1RM over 8 weeks.
Frequency: 2 sessions/week, 45-60 min/session.
Rest between sets: 1.5-3 minutes.
Load progressively increased across 4 two-week blocks
|
Participants perform lower-body resistance exercises (barbell squat, leg press, lunges, Romanian deadlift, leg curl, leg extension) at 60-80% 1RM over 8 weeks.
Frequency: 2 sessions/week, 45-60 min/session.
Rest between sets: 1.5-3 minutes.
Load progressively increased across 4 two-week blocks.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Sprint Speed - Electronic Timing Gates (40 m and 80 m)
Tidsramme: Baseline (Week 0) and Post-intervention (Week 8)
|
Sprint time measured in seconds over 40 m and 80 m distances using electronic timing gates.
Very high criterion validity (r ≈ 0.95-0.99)
and excellent test-retest reliability (ICC ≈ 0.90-0.99)
|
Baseline (Week 0) and Post-intervention (Week 8)
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Agility - T-Test
Tidsramme: Baseline (Week 0) and Post-intervention (Week 8)
|
Time (seconds) to complete the standard agility T-Test course assessing change-of-direction speed.
High construct and criterion validity (r ≈ 0.80-0.96);
high test-retest reliability (ICC ≈ 0.88-0.98)
|
Baseline (Week 0) and Post-intervention (Week 8)
|
|
Lower-Body Explosive Power - Standing Long Jump Test
Tidsramme: Baseline (Week 0) and Post-intervention (Week 8)
|
Distance (cm) achieved in the standing long jump as a measure of lower-body explosive power.
Strong concurrent validity with force-plate measures (r ≈ 0.76-0.91);
excellent reliability (ICC ≈ 0.97-0.99)
|
Baseline (Week 0) and Post-intervention (Week 8)
|
|
Movement Quality - Functional Movement Screen (FMS)
Tidsramme: Baseline (Week 0) and Post-intervention (Week 8)
|
Composite FMS score (0-21) assessing fundamental movement quality across 7 movement patterns.
Moderate to good construct validity (r ≈ 0.60-0.85);
moderate to excellent inter- and intra-rater reliability (ICC ≈ 0.74-0.98)
|
Baseline (Week 0) and Post-intervention (Week 8)
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Efterforskere
- Ledende efterforsker: Hafsah Gul Khattak, DPT, MS-NMPT, Ibadat International University, Islamabad (Iiui)
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Anslået)
1. april 2026
Primær færdiggørelse (Anslået)
1. juli 2026
Studieafslutning (Anslået)
1. juli 2026
Datoer for studieregistrering
Først indsendt
9. maj 2026
Først indsendt, der opfyldte QC-kriterier
15. maj 2026
Først opslået (Faktiske)
18. maj 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
18. maj 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
15. maj 2026
Sidst verificeret
1. maj 2026
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- IIUI/RERC/ADT/2026/04/285
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .